Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1485 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Helsinn Healthcare S.A.. (1/30/18). "Press Release: Helsinn and the Scientific Centre of Monaco Sign Collaboration Agreement". Lugano. 2018-01-30
Innate Pharma S.A.. (1/30/18). "Press Release: Innate Pharma and MedImmune Enter Clinical Trial Collaboration". Marseille. 2018-01-30
Abivax S.A.. (1/29/18). "Press Release: Abivax Appoints Carol L. Brosgart, M.D. to Its Board of Directors". Paris. 2018-01-29
Sanofi S.A.. (1/29/18). "Press Release: Sanofi to Acquire Ablynx for €3.9 Billion". Paris & Ghent. 2018-01-29
Novartis AG. (1/26/18). "Press Release: Advanced Accelerator Applications Receives FDA Approval for Lutathera for Treatment of Gastroenteropancreatic Neuroendocrine Tumors". Basel. 2018-01-26
Cynbiose Respiratory. (1/25/18). "Press Release: Cynbiose Respiratory, a New CRO Specialized in Respiratory Diseases and Aerosol Therapy, Announces the Beginning of Its Operations". Tours. 2018-01-25
Advicenne S.A.. (1/24/18). "Press Release: Advicenne Appoints Linda Law, MD as US Vice President, Clinical Development and Medical Affairs". Nîmes. 2018-01-24
bioMérieux S.A.. (1/23/18). "Press Release: bioMérieux – Fourth-Quarter 2017 Business Review". 2018-01-23
Sanofi S.A.. (1/22/18). "Press Release: Sanofi to Acquire Bioverativ for $11.6 Billion". Paris & Waltham, MA. 2018-01-22
Sanofi S.A.. (1/19/18). "Press Release: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee". Paris. 2018-01-19
Cellnovo. (1/17/18). "Press Release: Cellnovo Announces Its Q4 and Full Year 2017 Sales". Paris. 2018-01-17
HalioDx S.A.S.. (1/17/18). "Press Release: HalioDx Closed a Series B round of €18.5 Million (US$22.3 Million)". Marseille. 2018-01-17
TxCell S.A.. (1/17/18). "Press Release: TxCell Obtains Government Funding to Advance Its Lead CAR-Treg Program". Valbonne. 2018-01-17
Novolyze. (1/17/18). "Press Release: Novolyze Raises €2.2 Million to Lower the Risk of Foodborne Illnesses". 2018-01-17
PX’Therapeutics S.A.. (1/17/18). "Press Release: PX’Therapeutics and Advaxis to Collaborate for the Process Development of Lm Based Immunotherapies". Grenoble. 2018-01-17
Pherecydes Pharma S.A.. (1/16/18). "Press Release: Pherecydes Pharma Raises €8.7m ($10.3m). Series B Financing Led by GO CAPITAL and Two Historical Investors, ACE Management and Auriga Partners". Romainville. 2018-01-16
Owkin. (1/16/18). "Press Release: Owkin Closes $11 Million Series A Financing Round". New York, NY. 2018-01-16
bioMérieux S.A.. (1/15/18). "Press Release: CNES and bioMérieux Extend Their Collaboration on Aquapad, a Unique Water Quality Testing Tool". 2018-01-15
Ipsen S.A.. (1/12/18). "Press Release: Ipsen Appoints Richard Paulson Executive Vice-President and Chief Executive Officer of Ipsen North America". Paris. 2018-01-12
Truffle Capital. (1/10/18). "Press Release: Truffle Capital Announces the First Closing of Its New BioMedTech Venture Fund, Dedicated to Medical Devices and Biotechnology". Paris. 2018-01-10
Sanofi S.A.. (1/8/18). "Press Release: Sanofi and Regeneron to Accelerate and Expand Investment for Cemiplimab and Dupilumab Development Programs". Paris & Tarrytown, NY. 2018-01-08
Enterome S.A.. (1/4/18). "Press Release: Enterome Raises €32 Million ($38.5 Million) in a Series D Financing". Paris & Cambridge, MA. 2018-01-04
Nanobiotix S.A.. (12/26/17). "Press Release: 2017 Review and 2018 Expected Milestones". Paris & Cambridge, MA. 2017-12-26
TxCell S.A.. (12/18/17). "Press Release: TxCell Completes CAR-Treg Manufacturing Process Development and Provides Update to CMO Selection". Valbonne. 2017-12-18
bioMérieux S.A.. (12/15/17). "Press Release: Alexandre Mérieux Appointed Chairman and CEO of bioMérieux". Marcy l’Étoile. 2017-12-15
Arbiom Inc.. (12/14/17). "Press Release: Arbiom Led Consortium Receives €4M Refundable Loan from ADEME to Upscale Its Technology Allowing the Production of Sugars and Lignin from Forestry Material". Évry. 2017-12-14
Seventure Partners. (12/14/17). "Press Release: Seventure Partners’ Microbiome Portfolio is Reaching Critical Milestones in Current and Upcoming Clinical Trials". Paris. 2017-12-14
Servier. (12/13/17). "Press Release: Preliminary Data from Servier and Pfizer’s UCART19 Product Candidate Shows High Complete Remission Rate". 2017-12-13
Discngine S.A.S.. (12/11/17). "Press Release: Discngine Raises €1.1 Million ($1.3M) in Series A Funding Round". Paris. 2017-12-11
Sanofi S.A.. (12/11/17). "Press Release: FDA Approves Sanofi’s Admelog (insulin lispro injection)". Paris. 2017-12-11
Erytech Pharma. (12/8/17). "Press Release: Erytech Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML". Lyon. 2017-12-08
Abivax S.A.. (12/7/17). "Press Release: Abivax to Present in Plenary Session at the 8th International Conference on HIV Persistence during Therapy". Paris. 2017-12-07
Leti. (12/6/17). "Press Release: Innovation in the Diagnosis of Breast Cancer". 2017-12-06
Robocath S.A.S.. (12/6/17). "Press Release: Robocath Raises a Total of €6.4 million ($7.6M) in 2017". 2017-12-06
Genoscience Pharma S.A.S.. (12/6/17). "Press Release: Genoscience Pharma Receives FDA Approval for Phase Ib/IIa Study of GNS561 in Liver Cancer". Marseille. 2017-12-06
Agendia. (12/5/17). "Press Release: Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint BluePrint Breast Cancer Kit Co-Validation Study". Irvine, CA, Amsterdam & Paris. 2017-12-05
Advicenne S.A.. (12/5/17). "Press Release: Advicenne Raises €27 Million in Successful IPO on Euronext Paris [THIS PRESS RELEASE MAY NOT BE PUBLISHED, DISSEMINATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY TO THE USA, AUSTRALIA, CANADA OR JAPAN]". Nîmes. 2017-12-05
Cellectis S.A.. (12/4/17). "Press Release: Cellectis Appoints Elsy Boglioli to Executive Vice President, Strategy and Corporate Development". 2017-12-04
Sanofi S.A.. (12/4/17). "Press Release: Sanofi’s Toujeo Met Main Objective in Head-to-head Study versus Insulin Degludec". Paris. 2017-12-04
Leti. (12/4/17). "Press Release: Leti Researcher Reappointed Head of the European Technology Platform for Nanomedicine". 2017-12-04
Apix Analytics S.A.. (12/1/17). "Press Release: Apix Analytics Raises 8 Million Euros to Accelerate Its International Development". Grenoble. 2017-12-01
Leti. (11/30/17). "Press Release: Leti Develops Meg Technology To Improve Diagnosis Of Epilepsy and Guide Surgeons During Brain Surgery". 2017-11-30
Cellectis S.A.. (11/20/17). "Press Release: Cellectis Demonstrates Fine and Predictable Tuning of TALEN Gene Editing Targeting to Improve T-cell Adoptive Immunotherapy". New York, NY. 2017-11-20
Abivax S.A.. (11/20/17). "Press Release: Abivax Enrolls First Ulcerative Colitis Patient in New ABX464 Proof-of-Concept Clinical Trial". Paris. 2017-11-20
Erytech Pharma. (11/15/17). "Press Release: Erytech Announces Commencement of Trading of ADSs on Nasdaq and Full Exercise of Underwriters’ Option, Bringing Gross Proceeds of Global Offering to $144 Million [NOT FOR DISTRIBUTION IN AUSTRALIA, CANADA OR JA 2017-11-15
Cellectis S.A.. (11/13/17). "Press Release: Cellectis Reports Financial Results for Third Quarter and First Nine Months of 2017". New York, NY. 2017-11-13
Erytech Pharma. (11/10/17). "Press Release: Erytech Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market [Not for distribution in Australia, Canada and Japan]". Lyon. 2017-11-10
Sanofi S.A.. (11/9/17). "Press Release: Sanofi, Principia Agree to Develop Multiple Sclerosis Drug Candidate". Paris & South San Francisco, CA. 2017-11-09
Valneva S.E.. (11/9/17). "Press Release: Valneva Reports Strong Operational Performance for the First Nine Months of 2017". Lyon. 2017-11-09
Horama S.A.. (11/8/17). "Press Release: Horama Raises €19 million in a Series B Financing Round". Paris. 2017-11-08
Cerenis Therapeutics S.A.. (11/8/17). "Press Release: Cerenis Therapeutics Acquires Lypro Biosciences Expanding Its HDL Strategy into Immuno-oncology and Chemotherapeutic Drug Delivery". Toulouse & Lakeland, US. 2017-11-08
Valneva S.E.. (11/7/17). "Press Release: Valneva Signs $39.6 Million Ixiaro Supply Contract with US Government". Lyon. 2017-11-07
Erytech Pharma. (11/6/17). "Press Release: Erytech Announces Launch of Proposed Global Offering and NASDAQ Listing [Not for distribution in Australia, Canada and Japan]". Lyon. 2017-11-06
Erytech Pharma. (11/6/17). "Press Release: Erytech Reports Third Quarter 2017 Financial Results and Provides Business Update". Lyon. 2017-11-06
Cellectis S.A.. (11/6/17). "Press Release: FDA Lifts Clinical Hold on Cellectis Phase 1 Clinical Trials with UCART123 in AML and BPDCN". New York, NY. 2017-11-06
Euronext N.V.. (10/30/17). "Press Release: Theranexus Takes Its First Steps on Euronext Growth". Paris. 2017-10-30
Novartis AG. (10/28/17). "Press Release: Novartis PARADIGMS Data Show Children and Adolescents with MS Had an 82% Lower Relapse Rate with Gilenya vs. Interferon beta-1a". Basel. 2017-10-28
TxCell S.A.. (10/25/17). "Press Release: TxCell Renegotiates OCABSA Financing Option to Extend Cash Runway [Not for distribution in the United States of America, Canada, Australia and Japan]". Valbonne. 2017-10-25
Novartis AG. (10/25/17). "Press Release: Novartis Confirms Leadership in Multiple Sclerosis (MS) with Scientific Advancements and New Data presented at ECTRIMS". Basel. 2017-10-25
DBV Technologies S.A.. (10/20/17). "Press Release: DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut Allergic Patients Four to 11 Years of Age". 2017-10-20
TxCell S.A.. (10/19/17). "Press Release: Financial Information for the 3rd Quarter of 2017". Valbonne. 2017-10-19
Pharnext S.A.. (10/19/17). "Press Release: First-Half 2017". Paris. 2017-10-19
Servier. (10/19/17). "Press Release: Servier Establishes Strategic Research Alliance with Harvard University". 2017-10-19
bioMérieux S.A.. (10/18/17). "Press Release: bioMérieux – Business Review for the Nine Months ended September 30, 2017". 2017-10-18
Novacyt S.A.. (10/18/17). "Press Release: Proposed Admission to Trading on AIM and Successful Capital Riase of €9.7 Million [Not for US, AU, CA, JP or ZA or any other jurisdiction where unlawful]". Paris & Cambridge. 2017-10-18
Mutabilis S. A.. (10/17/17). "Press Release: Mutabilis Joins the European ENABLE Consortium to Fight Antibiotic Resistance". Paris. 2017-10-17
Bryan, Garnier & Co., Ltd.. (10/17/17). "Press Release: Bryan, Garnier & Co Strengthens Its Investment Banking Team with the Hiring of Marc-Antoine Janny as Vice President". Paris. 2017-10-17
Onxeo S.A.. (10/17/17). "Press Release: Onxeo Reports First Instance Decision from the Commercial Court of Paris in the Lawsuit against SpeBio/SpePharm". Paris. 2017-10-17
Sanofi S.A.. (10/16/17). "Press Release: Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis". Paris & Tarrytown, NY. 2017-10-16
Euronext N.V.. (10/13/17). "Press Release: Biom’up Lists on Euronext Paris to Finance Its Development". Paris. 2017-10-13
Sanofi S.A.. (10/12/17). "Press Release: Sanofi Invests €170 Million in New Vaccine Production Facility in France". Paris. 2017-10-12
Bryan, Garnier & Co., Ltd.. (10/11/17). "Press Release: Bryan Garnier & Co Acts as Sole Global Coordinator for Biom'Up's Landmark Euronext IPO, Raising up to €44 Million including Greenshoe". 2017-10-11
Erytech Pharma. (10/10/17). "Press Release: Erytech Announces Resubmission of European Marketing Authorization Application for Graspa in Acute Lymphoblastic Leukemia". Lyon. 2017-10-10
Bryan, Garnier & Co., Ltd.. (10/10/17). "Press Release: Bryan, Garnier & Co Grows Its Equity Research Healthcare Team". Paris. 2017-10-10
Bryan, Garnier & Co., Ltd.. (10/9/17). "Press Release: Bryan, Garnier & Co Grows Its Healthcare Franchise with the Hiring of Dr Anne Moore". Paris. 2017-10-09
Erytech Pharma. (10/6/17). "Press Release: Erytech Files Registration Statement for Proposed Initial Public Offering in the United States". Lyon. 2017-10-06
Cellectis S.A.. (10/4/17). "Press Release: Mathieu Simon, M.D. Cellectis’ EVP & Chief Operating Officer, to Serve as Interim Chief Medical Officer". New York, NY. 2017-10-04
Servier. (10/4/17). "Press Release: Servier Opts for Saclay as Its Future Research Centre". 2017-10-04
Global Bioenergies S.A.. (10/3/17). "Press Release: Global Bioenergies Strengthens Its Management Team". Évry. 2017-10-03
Global Bioenergies S.A.. (10/2/17). "Press Release: Publication of the half-year results to 30/06/2017. Net Loss for the Group of €7.8 Million in the First Half of 2017". Évry. 2017-10-02
Transgene S.A.. (10/2/17). "Press Release: Transgene and Randox Sign Collaboration to Develop Innovative Multifunctional Oncolytic Virotherapies for Solid Tumors". Strasbourg & Belfast. 2017-10-02
Streck, Inc.. (9/28/17). "Press Release: Streck Signs Distribution Agreement with Orgentec SASU". La Vista, NE. 2017-09-28
Abivax S.A.. (9/28/17). "Press Release: Abivax’s ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial". Paris. 2017-09-28
LNC Therapeutics. (9/27/17). "Press Release: LNC Therapeutics Raises € 6.5 Million and Reinforces Its R&D in the Microbiota Field". Bordeaux. 2017-09-27
Endress+Hauser AG. (9/27/17). "Press Release: Endress+Hauser Inaugurates New Campus in Lyon". 2017-09-27
Eligo Bioscience. (9/26/17). "Press Release: Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome". London. 2017-09-26
Transgene S.A.. (9/21/17). "Press Release: Transgene Launches Invir.IOŹ, its Integrated Platform for the Next Generation of Multifunctional Oncolytic Viruses". Strasbourg. 2017-09-21
Abivax S.A.. (9/20/17). "Press Release: Abivax First-half 2017 Financial Results and Update". Paris. 2017-09-20
BioSerenity. (9/20/17). "Press Release: BioSerenity, Digital Health Champion, Raises 15 Million Euros". Paris. 2017-09-20
Enterome S.A.. (9/20/17). "Press Release: Enterome to Move its Research Laboratories to Genopole, France’s First Biocluster". Évry. 2017-09-20
Abivax S.A.. (9/20/17). "Press Release: Abivax Receives French Regulatory Approval to Begin Clinical Trial of ABX464 in Ulcerative Colitis". Paris. 2017-09-20
Transgene S.A.. (9/19/17). "Press Release: First Patient Treated in a Phase 1b/2 Trial of TG4001 in Combination with Avelumab in HPV-Positive Cancers". Strasbourg. 2017-09-19
Abivax S.A.. (9/18/17). "Press Release: First Patient Dosed in Three-month Cohort of Phase 2A Study of Oral ABX464 in HIV-supressed Patients". Paris. 2017-09-18
Transgene S.A.. (9/13/17). "Press Release: First Half-year 2017 in Line with Our Objectives – All Clinical Programs Progressing and New Collaboration Agreements Signed". Strasbourg. 2017-09-13
DNA Script. (9/12/17). "Press Release: DNA Script Raises €11 Million ($13 Million) in Series A Financing Led by Illumina Ventures to Advance Development of Its DNA Synthesis Technology". Paris. 2017-09-12
Erytech Pharma. (9/11/17). "Press Release: Erytech Reports First Half 2017 Financial Results and Provides Business Update". Lyon. 2017-09-11
Transgene S.A.. (9/11/17). "Press Release: Transgene Receives FDA IND Approval to Begin a Clinical Trial with TG4010 + Nivolumab + Chemotherapy in the First-Line Treatment of Lung Cancer (NSCLC)". Strasbourg. 2017-09-11
Roche. (9/11/17). "Press Release: Onxeo Announces Top-line Results from ReLive Phase III Study of Livatag in Advanced Hepatocellular Carcinoma". Paris. 2017-09-11
Erytech Pharma. (9/8/17). "Press Release: Erytech Announces Positive Full Results from Phase 2b Study of Eryaspase in Combination with Chemotherapy for Treatment of Metastatic Pancreatic Cancer in Second-Line". Lyon. 2017-09-08
HalioDx S.A.S.. (9/8/17). "Press Release: HalioDx Announces Clinical Collaboration with PRODIGE to Evaluate Immunoscore in IDEA1 Stage III Colon Cancer Study". Marseille. 2017-09-08
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top